相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
European cancer mortality predictions for the year 2014
M. Malvezzi et al.
ANNALS OF ONCOLOGY (2014)
Identifying molecular subtypes related to clinicopathologic factors in pancreatic cancer
Shinuk Kim et al.
BIOMEDICAL ENGINEERING ONLINE (2014)
Src Inhibition Is Still a Relevant Target in Pancreatic Cancer
Thomas J. George et al.
ONCOLOGIST (2014)
Removing batch effects for prediction problems with frozen surrogate variable analysis
Hilary S. Parker et al.
PEERJ (2014)
High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma
Albrecht Stenzinger et al.
BMC CANCER (2013)
Recent progress in pancreatic cancer
Christopher L. Wolfgang et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Pregnane X Receptor (PXR) at the Crossroads of Human Metabolism and Disease
Ioannis Koutsounas et al.
CURRENT DRUG METABOLISM (2013)
3D structures and ligand specificities of nuclear xenobiotic receptors CAR, PXR and VDR
Baojian Wu et al.
DRUG DISCOVERY TODAY (2013)
A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors
David S. Hong et al.
INVESTIGATIONAL NEW DRUGS (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Evolution and dynamics of pancreatic cancer progression
S. Yachida et al.
ONCOGENE (2013)
The sva package for removing batch effects and other unwanted variation in high-throughput experiments
Jeffrey T. Leek et al.
BIOINFORMATICS (2012)
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Andrew V. Biankin et al.
NATURE (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Selective Mechanism-Based Inactivation of CYP3A4 by CYP3cide (PF-04981517) and Its Utility as an In Vitro Tool for Delineating the Relative Roles of CYP3A4 versus CYP3A5 in the Metabolism of Drugs
Robert L. Walsky et al.
DRUG METABOLISM AND DISPOSITION (2012)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li et al.
BMC BIOINFORMATICS (2011)
Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells
Agnes Basseville et al.
MOLECULAR CANCER (2011)
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A. Collisson et al.
NATURE MEDICINE (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Expressions of Cytochrome P450, UDP-Glucuronosyltranferase, and Transporter Genes in Monolayer Carcinoma Cells Change in Subcutaneous Tumors Grown As Xenografts in Immunodeficient Nude Mice
Michiko Sugawara et al.
DRUG METABOLISM AND DISPOSITION (2010)
Profiling the expression of cytochrome P450 in breast cancer
Graeme I. Murray et al.
HISTOPATHOLOGY (2010)
Towards a knowledge-based Human Protein Atlas
Mathias Uhlen et al.
NATURE BIOTECHNOLOGY (2010)
Pancreatic Cancer
Manuel Hidalgo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Factors underlying sensitivity of cancers to small-molecule kinase inhibitors
Pasi A. Jaenne et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Identification of an Endogenous Ligand Bound to a Native Orphan Nuclear Receptor
Xiaohui Yuan et al.
PLOS ONE (2009)
Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues
Petr Pavek et al.
CURRENT DRUG METABOLISM (2008)
Identification of the human enzymes involved in the oxidative metabolism of dasatinib: An effective approach for determining metabolite formation kinetics
Lifei Wang et al.
DRUG METABOLISM AND DISPOSITION (2008)
Metabolism and disposition of dasatinib after oral administration to humans
Lisa J. Christopher et al.
DRUG METABOLISM AND DISPOSITION (2008)
Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity
L. Vermeulen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
Drug metabolism by tumours: its nature, relevance and therapeutic implications
Michael Michael et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2007)
Targeting cytochrome P450 enzymes: A new approach in anti-cancer drug development
Robert D. Bruno et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Differential metabolism of gefitinib and erlotinib by human cytochrome P450 enzymes
Jing Li et al.
CLINICAL CANCER RESEARCH (2007)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Cytochrome P450 levels are altered in patients with esophageal squamous-cell carcinoma
I. Bergheim et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Mechanisms of cytochrome P450 induction
Leslie M. Tompkins et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2007)
Inhibition of Src expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model
JG Trevino et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Profiling cytochrome P450 expression in ovarian cancer:: Identification of prognostic markers
D Downie et al.
CLINICAL CANCER RESEARCH (2005)
Tumoral drug metabolism: Overview and its implications for cancer therapy
M Michael et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance - Focus on tamoxifen, paclitaxel and imatinib metabolism
B Rochat
CLINICAL PHARMACOKINETICS (2005)
Expression of cytochrome P450 in lung tumor
N Gharavi et al.
CURRENT DRUG METABOLISM (2004)
CYP3A4, CYP2C9 and CYP2B6 expression and ifosfamide turnover in breast cancer tissue microsomes
R Schmidt et al.
BRITISH JOURNAL OF CANCER (2004)
The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR)
O Burk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cytochrome P450 3A and their regulation
O Burk et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
Expression of cytochrome P450 in tumor tissues and its association with cancer development
T Oyama et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Cytochrome P450 CYP3A4/5 expression as a biomarker of outcome in osteosarcoma
HR Dhaini et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism
A Westlind-Johnsson et al.
DRUG METABOLISM AND DISPOSITION (2003)
The orphan nuclear receptor HNF4α determines PXR- and CAR-mediated xenobiotic induction of CYP3A4
RG Tirona et al.
NATURE MEDICINE (2003)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
P Kuehl et al.
NATURE GENETICS (2001)
Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line
J Hukkanen et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2000)
分享论文
